Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors

Proteasome inhibitors (PIs) have markedly improved response rates as well as the survival of multiple myeloma (MM) patients over the past decade and have become an important foundation in the treatment of MM patients. Unfortunately, the majority of patients either relapses or becomes refractory to p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Control Release
Hauptverfasser: Hu, Hangting, Petrosyan, Armen, Osna, Natalia A., Liu, Tong, Olou, Appolinaire A., Alakhova, Daria Y., Singh, Pankaj K., Kabanov, Alexander V., Faber, Edward A., Bronich, Tatiana K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822276/
https://ncbi.nlm.nih.gov/pubmed/31121280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.05.026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge